Align Technology (ALGN): ALGN stock is up 5.1% today. Clovis Oncology Inc (CLVS): CLVS stock is up 2.8% today. Myriad Genetics (MYGN): MYGN stock is up 3.1%, marking the fifth consecutive day the stock has increased. Abbott …
RADNOR, PA / ACCESSWIRE / May 10, 2018 / Kaskela Law LLC reminds Myriad Genetics, Inc. (NASDAQ: MYGN) ("Myriad" or the "Company") shareholders ... Following this disclosure, shares of the Company's stock fell $4.01 per …
The stock has risen 29 percent in the last 12 months. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MYGN …
MYGN) traded down as much as 16% Wednesday morning following a late Tuesday announcement that the company’s president and CEO is retiring and that the company is lowering its fiscal-year guidance. The last time the stock fell this …
... Having more Current Assets provides flexibility for MYGN. This also supports the short squeeze possibility. If you read my post on Accenture and how share buybacks create a floor to the stock price, MYGN has also been buying back …
May 06, 2018 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that a shareholder class action lawsuit has been filed against Myriad Genetics, Inc. (NASDAQ:MYGN) (“Myriad” or ... shares of the Company’s stock fell $4.01 per share, or …
RADNOR, PA / ACCESSWIRE / May 8, 2018 / Kaskela Law LLC alerts Myriad Genetics, Inc. (NASDAQ: MYGN) ("Myriad" or the "Company") investors ... Following this disclosure, shares of the Company's stock fell $4.01 per share, …
Shareholder rights law firm Robbins Arroyo LLP announces that purchasers of Myriad Genetics, Inc. (NasdaqGS: …
Shares closed on Monday at $7.23. The company reports earnings on November 6. Myriad Genetics Inc. (NASDAQ: MYGN) is a biotech stock that has hammered the shorts so far this year, up 75%. The company announced Monday …